The drug company is the 17th to agree to lower its prices as part of the administration’s Most Favored Nation initiative. It will make a new gene therapy available free.
Trump unveils new drug price deal with Regeneron amid affordability push
Political Leaning Analysis
Score: -0.28 •
Center / Neutral
Left
Center
Right
Story Timeline
Wed 11:00 - Washington Examiner
Trump’s ‘Most Favored Nation’ drug pricing push risks undermining pro-life legacy
Thu 20:07 - Washington Post
Trump unveils new drug price deal with Regeneron amid affordability push